Will Brexit and Trump Affect Future Pharmaceutical Packaging and Labeling Regulations?

The Pharmaceutical industry is gradually coming into compliance with new regulatory requirements including the Falsified Medicines Directive (FMD) for Britain and the Drug Supply Chain Security Act (DSCSA) for the US. An important deadline coming up in November 2017 mandates that manufacturers must include product identifiers, serial numbers, lot numbers, and expiration dates in their[…]

President Trump’s China Trade Stance Concerns Supplements Industry

Hank Schultz examined how the Dietary Supplements industry is reacting to President Donald Trump, and insiders are nervous. Donald Trump is well known for making controversial statements that might become policy, but the anti-China tone concerns many who rely on Chinese ingredients. Trump has nominated Peter Navarro, Ph.D., a Harvard-educated economist as head of the[…]

Trump Declares War on Drug Pricing – Or Did He?

This story is continually developing. If Trump his policies once more, we’ll post an update highlighting the new details. In January, President Donald Trump loudly declared that pharmaceutical companies are “getting away with murder” with what they charge the government and patients for medications. Unsurprisingly, his statement drove numerous drug stocks down and effectively put[…]